GeneGoCell Inc. published an Insight summarizing three 2026 FDA publications on genome-editing safety and their implications for platform-based genome-editing programs.
Published
Signal category
Research & Knowledge
Quote
“Our latest GeneGoCell Inc. Insight (https://lnkd.in/gadErJAv) looks at #threeFDAPublications issued in the past 5 months in 2026 and what they may mean practically for genome-editing programs preparing for IND.”
— Elizabeth Yan Zhang, MBA, PhD|GeneGoCell Inc. team
Company
GeneGoCell Inc.
GeneGoCell provides high-quality, innovative and fast-TAT customized solutions in GENE (NGS) and CELL (flow cytometry).
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 17 employees
We are a San Diego Life Science Company supporting the Gene and Cell Therapy industry by providing one-stop custom NGS and Flow Cytometry Solutions, from assay design to data analysis and report, all from our CLIA, and GLP/GMP compliant labs. We embrace the latest technologies, innovate and optimize workflows, and forge strategic partnerships with industry leaders to offer the highest level of client support. Our service lines cover: Genome Editing Verification (GEV); and Custom NGS Services. We provide our services observing your individual needs for discretion and confidentiality. Our in-house bioinformatics team has developed our proprietary algorithms and provide unmatched support for the analysis and processing of all project data. Finally, we have supported multiple approved IND filings for our clients. This experience and our unrivaled attention to client needs makes GeneGoCell the teammate you want on the road to your own success and approval. We Value: Industry-Leading Turnaround Time Service Quality Cost-Effectiveness Genome-Editing Verification Solutions: On-Target Verification Off-Target Site Identification and Verification Translocation Identification Transgene Integration Sites and Integrity RNAseq (including mRNA and miRNA) Our GEV services are fully customizable and provide results in industry leading turn-around time with 90% of projects completed in 1 week and 100% within 2 weeks. G-Screen: Single clone genotyping (high throughput screening/selection) - From as few as 500 cells per well, with 3-day average turn-around time. Find out why our client retention is 100% Contact us today for more information or for a custom quote for service.
Founded 2020